News: 2010
- Researchers discover a rotational motion of cells that may have implications for future breast cancer research
January 30, 2012
- Two anti-HER2 drugs may be better than one in the neoadjuvant setting
January 18, 2012
- Study suggests red wine may provide breast cancer benefit
January 11, 2012
- ACS predicts over 290,000 women and men to be diagnosed with in situ and invasive breast cancer in 2012
January 6, 2012
- NIH Scientists Find Pathway to Regulate Cancer Growth and Metastasis in Mice
December 21, 2011
- SABCS 2011: Dual HER2 Blockade Significantly Extends Progression-Free Survival
December 8, 2011
- SABCS 2011: Exemestane Plus Everolimus Increased Progression-Free Survival for Women With Metastatic Breast Cancer
December 8, 2011
- SABCS 2011: Zoledronic Acid Shows Long-Term Benefit in Survivorship for Premenopausal ER-Positive Breast Cancer
December 7, 2011
- IOM Releases Report on Breast Cancer and the Environment
December 7, 2011
- SABCS 2011: New Test Predicts Risk for Recurrence for Patients with DCIS
December 7, 2011
- HER2 status of metastatic tumor may differ from primary tumor
November 30, 2011
- FDA Commissioner Revokes Approval of Avastin for Breast Cancer
November 18, 2011
- New study suggests most women with breast cancer were not saved by mammograms, despite beliefs
October 26, 2011
- Study finds annual mammography screening produces many false-positives
October 18, 2011
- New Tool for Predicting Recurrence Risk
October 18, 2011
- Eliminating the anthracycline from Herceptin regimens reduces cardiac complications without worsening survival
October 5, 2011
- Combination therapy improves progression-free survival in advanced breast cancer patients - BOLERO-2 Trial
October 5, 2011
- Some breast tumors change hormonal status throughout the course of disease
September 28, 2011
- Breast Cancer Incidence Rate Projected to Stay the Same through 2016
September 27, 2011
- Earlier age of onset of BRCA-related cancers in subsequent generations
September 13, 2011

Understanding Research and Evidence